Multiple surgeons perform general surgery procedures in
“SurgiBot has promise as a patient-side robotic system for precise dissection during many types of surgical procedures,” Gagner said. “As an experienced laparoscopic surgeon, I appreciate the benefits of robotic precision, strength and ergonomics while remaining in control of the operative site in the sterile field. The system also allows the surgeon to control multiple instruments and a camera and therefore reduce reliance on other assistants during procedures.”
“We’re pleased to have achieved this important milestone in the development of SurgiBot,” said
The company plans to submit a 510(k) application for clearance with the
The SurgiBot is a minimally invasive, patient-side robotic surgery system. The system is designed to utilize a small incision – often hidden inside the belly button. SurgiBot provides multiple channels to the surgeon capable of accommodating both rigid and flexible articulating instruments which offer dexterity in complex surgical tasks. The instruments are designed to give the surgeon needed strength and precision in an ergonomically comfortable manner while maintaining tactile feel. SurgiBot also integrates high-definition, three-dimensional visualization to restore the depth perception that’s lost in traditional laparoscopic procedures. The system’s size and mobility are designed for easy repositioning during multi-quadrant surgery. As a patient-side robotic system, the surgeon maintains direct access to the sterile field throughout the procedure. By integrating the benefits of advanced technology and visualization in a patient-side surgical system, TransEnterix believes the SurgiBot will advance minimally invasive surgery for patients, surgeons and hospitals.
TransEnterix is a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery. The company is focused on the development and commercialization of SurgiBot, a patient-side minimally invasive surgical robotic system. For more information, visit the company’s website at www.transenterix.com.
Forward Looking Statements
This press release includes statements relating to our SurgiBot system and our current regulatory and commercialization plans for the system.These statements and other statements regarding our future plans and goals constitute "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control, and which may cause results to differ materially from expectations and include whether the SurgiBot will provide precise dissection during surgical procedures, whether the SurgiBot will allow for surgeons to be in control of multiple instruments and a camera, therefore reducing the reliance on other assistants during procedures; and whether the Company will submit a 510(k) application for clearance with the U.S.